|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
45,510,000 |
Market
Cap: |
17.34(B) |
Last
Volume: |
20,609,857 |
Avg
Vol: |
7,105,540 |
52
Week Range: |
$381.02 - $381.02 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile ABIOMED is a provider of medical devices that provide circulatory support and oxygenation. Co.'s existing products include: Impella 2.5®, which is a percutaneous heart pump with a motor and sensors; Impella CP®, which is primarily used by either interventional cardiologists to support patients in the cath lab or by cardiac surgeons in the heart surgery suite; Impella 5.0® and Impella LD®, which are percutaneous heart pumps with motors and sensors for use primarily in the heart surgery suite; Impella 5.5®, which is designed to be a percutaneous heart pump with motors and sensors; and Abiomed Breethe OXY-1 System, which is a portable external respiratory assistance device.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
17,044 |
Total Sell Value |
$0 |
$0 |
$0 |
$5,919,264 |
Total People Sold |
0 |
0 |
0 |
5 |
Total Sell Transactions |
0 |
0 |
0 |
10 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Sutter Martin P |
Director |
|
2019-02-05 |
4 |
S |
$350.05 |
$1,425,390 |
D/D |
(4,072) |
206,476 |
|
- |
|
Sutter Martin P |
Director |
|
2019-02-04 |
4 |
S |
$350.12 |
$6,985,575 |
D/D |
(19,943) |
210,548 |
|
- |
|
Weber David M |
Chief Operating Officer |
|
2019-01-25 |
4 |
AS |
$350.37 |
$8,435,192 |
D/D |
(24,000) |
147,842 |
|
- |
|
Weber David M |
Chief Operating Officer |
|
2019-01-25 |
4 |
OE |
$22.44 |
$545,660 |
D/D |
24,000 |
171,842 |
|
- |
|
Sutter Martin P |
Director |
|
2018-12-31 |
4 |
A |
$325.04 |
$16,902 |
D/D |
52 |
230,939 |
|
- |
|
Van Gorder Chris |
Director |
|
2018-12-31 |
4 |
A |
$325.04 |
$16,577 |
D/D |
51 |
6,426 |
|
- |
|
Minogue Michael R |
Chairman, President, CEO |
|
2018-11-21 |
4 |
GA |
$0.00 |
$0 |
I/I |
85,040 |
85,040 |
|
- |
|
Minogue Michael R |
Chairman, President, CEO |
|
2018-11-21 |
4 |
GD |
$0.00 |
$0 |
I/I |
85,040 |
1,822 |
|
- |
|
Minogue Michael R |
Chairman, President, CEO |
|
2018-11-20 |
4 |
GA |
$0.00 |
$0 |
I/I |
23,810 |
32,810 |
|
- |
|
Minogue Michael R |
Chairman, President, CEO |
|
2018-11-20 |
4 |
GD |
$0.00 |
$0 |
I/I |
23,810 |
86,862 |
|
- |
|
Greenfield Andrew J |
VP Healthcare Solutions |
|
2018-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
24 |
43,978 |
|
- |
|
Van Gorder Chris |
Director |
|
2018-09-30 |
4 |
A |
$449.75 |
$16,191 |
D/D |
36 |
6,375 |
|
- |
|
Sutter Martin P |
Director |
|
2018-09-30 |
4 |
A |
$449.75 |
$17,091 |
D/D |
38 |
230,887 |
|
- |
|
Howley Michael G |
VP, Global Sales & Marketing |
|
2018-09-25 |
4 |
AS |
$425.00 |
$4,325,000 |
D/D |
(10,000) |
50,492 |
|
- |
|
Howley Michael G |
VP, Global Sales & Marketing |
|
2018-09-25 |
4 |
OE |
$23.15 |
$231,500 |
D/D |
10,000 |
60,492 |
|
- |
|
Greenfield Andrew J |
VP Healthcare Solutions |
|
2018-09-24 |
4 |
AS |
$420.00 |
$2,100,000 |
D/D |
(5,000) |
43,954 |
|
- |
|
Greenfield Andrew J |
VP Healthcare Solutions |
|
2018-09-24 |
4 |
OE |
$21.55 |
$107,750 |
D/D |
5,000 |
48,954 |
|
- |
|
Sutter Martin P |
Director |
|
2018-08-30 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,000 |
230,849 |
|
- |
|
Greenfield Andrew J |
VP Healthcare Solutions |
|
2018-08-29 |
4 |
S |
$395.00 |
$1,753,800 |
D/D |
(4,440) |
43,954 |
|
- |
|
Minogue Michael R |
Chairman, President, CEO |
|
2018-08-09 |
4 |
GA |
$0.00 |
$0 |
I/I |
64,018 |
110,672 |
|
- |
|
Minogue Michael R |
Chairman, President, CEO |
|
2018-08-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
64,018 |
318,890 |
|
- |
|
Puhy Dorothy E |
Director |
|
2018-08-09 |
4 |
D |
$376.01 |
$203,421 |
D/D |
(541) |
21,823 |
|
- |
|
Van Gorder Chris |
Director |
|
2018-08-08 |
4 |
D |
$376.01 |
$242,902 |
D/D |
(646) |
6,339 |
|
- |
|
Van Gorder Chris |
Director |
|
2018-08-08 |
4 |
A |
$0.00 |
$0 |
D/D |
531 |
6,985 |
|
- |
|
Thomas Paul |
Director |
|
2018-08-08 |
4 |
D |
$376.01 |
$222,222 |
D/D |
(591) |
12,112 |
|
- |
|
740 Records found
|
|
Page 12 of 30 |
|
|